An Exploration of Key Issues in IBD: A CME/CE-Certified Microlearning Series

In this concise video, review recommendations for therapeutic drug monitoring of TNF-α inhibitor therapy and hear expert discussion of key data informing second-line treatment decisions of moderate to severe UC and CD following TNF-α inhibitor failure.

Bruce E. Sands, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Released: May 24, 2021 Expired: May 23, 2022

Learn about current guideline recommendations for therapeutic drug monitoring of TNF-α inhibitor therapy and review key data informing second-line treatment decisions of moderate to severe UC and CD following TNF-α inhibitor failure.

Bruce E. Sands, MD, MS Released: May 24, 2021

My take on TDM for patients receiving TNF-α inhibitors for IBD.

Bruce E. Sands, MD, MS Released: June 3, 2021